Form 8-K BELLICUM PHARMACEUTICALS For: Mar 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Bellicum Pharma (BLCM) Posts Q4 GAAP Loss of $18.99/Share
March 11, 2015 4:15 PM EDTBellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($18.99), which may not compare with the analyst estimate of ($0.37). Revenue for the quarter came in at $0 versus the consensus estimate of $600 thousand.
The higher net loss amounts for the 2014 periods were due primarily to... More
